Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.
Clinical cancer research : an official journal of the American Association for Cancer Research（2023）
摘要
In this open-label trial, treatment of refractory viral infections/disease in allo-HCT recipients with posoleucel was feasible, safe, and effective.
更多查看译文
关键词
viral infections,refractory viral infections,off-the-shelf,multivirus-specific,t-cell,post-hct
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要